Cordatus Wealth Management LLC boosted its holdings in shares of Colgate-Palmolive (NYSE:CL) by 19.7% in the first quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 9,400 shares of the company’s stock after acquiring an additional 1,550 shares during the period. Cordatus Wealth Management LLC’s holdings in Colgate-Palmolive were worth $644,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors have also modified their holdings of the stock. Lynch & Associates IN grew its stake in shares of Colgate-Palmolive by 0.6% in the first quarter. Lynch & Associates IN now owns 28,930 shares of the company’s stock worth $1,983,000 after acquiring an additional 160 shares during the period. First National Bank of Omaha grew its stake in shares of Colgate-Palmolive by 1.2% in the first quarter. First National Bank of Omaha now owns 13,499 shares of the company’s stock worth $925,000 after acquiring an additional 160 shares during the period. Private Capital Group LLC grew its stake in shares of Colgate-Palmolive by 4.6% in the first quarter. Private Capital Group LLC now owns 3,801 shares of the company’s stock worth $261,000 after acquiring an additional 168 shares during the period. HighPoint Advisor Group LLC grew its stake in shares of Colgate-Palmolive by 2.5% in the fourth quarter. HighPoint Advisor Group LLC now owns 7,799 shares of the company’s stock worth $520,000 after acquiring an additional 193 shares during the period. Finally, Mitchell Mcleod Pugh & Williams Inc. grew its stake in shares of Colgate-Palmolive by 2.4% in the first quarter. Mitchell Mcleod Pugh & Williams Inc. now owns 8,521 shares of the company’s stock worth $584,000 after acquiring an additional 196 shares during the period. 75.95% of the stock is owned by institutional investors.

Shares of NYSE CL opened at $71.97 on Monday. The company has a debt-to-equity ratio of 32.25, a current ratio of 1.07 and a quick ratio of 0.74. The company has a market cap of $61.79 billion, a P/E ratio of 24.23, a price-to-earnings-growth ratio of 4.72 and a beta of 0.81. Colgate-Palmolive has a 12-month low of $57.41 and a 12-month high of $73.10.

Colgate-Palmolive (NYSE:CL) last announced its earnings results on Friday, April 26th. The company reported $0.67 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.66 by $0.01. The company had revenue of $3.88 billion during the quarter, compared to analyst estimates of $3.86 billion. Colgate-Palmolive had a net margin of 15.08% and a negative return on equity of 3,730.37%. The firm’s quarterly revenue was down 2.9% compared to the same quarter last year. During the same period in the previous year, the business posted $0.74 earnings per share. Equities research analysts anticipate that Colgate-Palmolive will post 2.83 EPS for the current year.

The firm also recently announced a quarterly dividend, which was paid on Wednesday, May 15th. Investors of record on Friday, April 19th were given a dividend of $0.43 per share. This represents a $1.72 annualized dividend and a yield of 2.39%. This is a positive change from Colgate-Palmolive’s previous quarterly dividend of $0.42. The ex-dividend date of this dividend was Wednesday, April 17th. Colgate-Palmolive’s payout ratio is 57.91%.

In other Colgate-Palmolive news, Vice Chairman Dennis J. Hickey sold 6,060 shares of Colgate-Palmolive stock in a transaction that occurred on Tuesday, February 19th. The shares were sold at an average price of $66.37, for a total transaction of $402,202.20. Following the transaction, the insider now owns 407,294 shares of the company’s stock, valued at $27,032,102.78. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, CEO Ian M. Cook sold 22,634 shares of Colgate-Palmolive stock in a transaction that occurred on Tuesday, February 19th. The shares were sold at an average price of $66.31, for a total transaction of $1,500,860.54. Following the transaction, the chief executive officer now directly owns 1,162,793 shares in the company, valued at approximately $77,104,803.83. The disclosure for this sale can be found here. Insiders have sold 381,131 shares of company stock valued at $26,771,200 over the last 90 days. 1.14% of the stock is currently owned by company insiders.

CL has been the subject of a number of research analyst reports. BNP Paribas upgraded shares of Colgate-Palmolive from an “underperform” rating to a “neutral” rating and lifted their price target for the stock from $56.00 to $67.00 in a research note on Monday, February 11th. Jefferies Financial Group reiterated a “hold” rating and issued a $61.00 price target on shares of Colgate-Palmolive in a research note on Friday, February 1st. JPMorgan Chase & Co. upgraded shares of Colgate-Palmolive from an “underweight” rating to a “neutral” rating and lifted their price target for the stock from $62.00 to $70.00 in a research note on Monday, April 29th. Morgan Stanley set a $62.00 price target on shares of Colgate-Palmolive and gave the stock a “hold” rating in a research note on Tuesday, January 29th. Finally, Wells Fargo & Co restated a “hold” rating and set a $57.00 target price on shares of Colgate-Palmolive in a research report on Friday, January 25th. One equities research analyst has rated the stock with a sell rating, thirteen have issued a hold rating and five have assigned a buy rating to the company. The company presently has an average rating of “Hold” and a consensus price target of $69.69.

COPYRIGHT VIOLATION NOTICE: “Cordatus Wealth Management LLC Acquires 1,550 Shares of Colgate-Palmolive (CL)” was posted by Watch List News and is owned by of Watch List News. If you are viewing this article on another site, it was copied illegally and republished in violation of US & international trademark and copyright law. The correct version of this article can be viewed at https://www.watchlistnews.com/cordatus-wealth-management-llc-acquires-1550-shares-of-colgate-palmolive-cl/3016439.html.

Colgate-Palmolive Company Profile

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products worldwide. The company operates through two segments, Oral, Personal and Home Care; and Pet Nutrition. It offers oral care products, including toothpastes, toothbrushes, and mouthwashes, as well as pharmaceutical products for dentists and other oral health professionals; and personal care products, such as liquid hand soaps, bar soaps, shower gels, deodorants and antiperspirants, skin care products, and shampoos and conditioners.

Recommended Story: How to interpret a stock’s beta number

Want to see what other hedge funds are holding CL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Colgate-Palmolive (NYSE:CL).

Institutional Ownership by Quarter for Colgate-Palmolive (NYSE:CL)

Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.